developmental disorders
Conditions
Interventions
QEEG measurements under four conditions:
1. Resting with eyes open
2. Resting with eyes closed
3. During an attention task
4. During a motor task.
Parents will have to complete two questionnaires (SDQ and ADHD-Rating Scale). Boys with ADHD who are taking methylphenidate are measured twice: once on a day with medication
Sponsors
VieCuri Medical Centre, Venlo, The Netherlands
Eligibility
Inclusion criteria
Inclusion criteria: 1. Boys between 6 and 12 years with the diagnosis of ADHD or ASD conform DSM-IV criteria, with or without co-morbidities like Gilles de la Tourette, DCD or dyslexia; 2. Control group of healthy boys between 6 and 12 years.
Exclusion criteria
Exclusion criteria: 1. Children with organic brain-defects, epilepsy, migraine, other psychiatric disorders than developmental disorders and children with influenza or fever; 2. Besides the boys in the control group should not have a developmental disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QEEG-signals of twenty electrodes, measured as the average contribution in microvolt of each frequency band on each electrode in four different conditions. | — |
Secondary
| Measure | Time frame |
|---|---|
| QEEG-signals in boys with ADHD, measured on a day with methylphenidate medication and on a day without, compared with their behavioural characteristics as measured by the ADHD-Rating Scale. | — |
Contacts
Public ContactA. Driessen
Secretariat of Department of Pediatrics, VieCuri Medical Centre, Tegelseweg 210
Outcome results
None listed